AI Therapeutics
520 Old Whitfield Street
Guilford, CT 06437
Phone: 203-441-3171
Website: https://www.ai-therapeutics.com/
Email: pboni@ai-thera.com
General Information:
AI Therapeutics is a clinical stage biotechnology company focused on bringing life-saving drugs to patients with rare, underserved diseases.
Research Activities:
The company is currently developing three different compounds in multiple indications:
- AIT-101: First-in-class PIKfyve kinase inhibitor in Phase 2 for ALS
- LAM-001: Proprietary inhaled formulation of rapamycin, entering Phase 2 trials for three lung disorders — PAH, PS and BOS
- AIT-102: Proprietary analogue of mithramycin, in preclinical development for oncology indications including Ewing Sarcoma, Rhabdoid Tumor, and SWI/SNF mutated or dysregulated tumors